Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
behind it, the key is to look closely at what the numbers say about its valuation. The stock closed at US$22.60 recently, with a 3.2% decline over the last 7 days, a roughly flat 0.2% return over 30 days, and small declines of 2.4% year to date and 0.9% over 1 year. The 3 year return is 7.8% and the 5 year return is a very large gain. Recent coverage of Catalyst Pharmaceuticals has continued to focus on its position in the US pharmaceuticals and biotech space and the long term trajectory of its share price. This helps frame these short term price moves in a broader context and keeps valuation in the spotlight for investors who are tracking whether the current price still lines up with fundamentals. On our simple valuation framework, Catalyst Pharmaceuticals scores 6 out of 6 for being undervalued across the checks we run. Next we will walk through the usual valuation approaches you might use, then finish with a way of looking at value that can tie all of those methods together.
Show less
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- Does Forbes' Small-Cap Honor for Sales Growth Reshape the Bull Case For Catalyst Pharmaceuticals (CPRX)? [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap CompaniesGlobeNewswire
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) [Yahoo! Finance]Yahoo! Finance
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)GlobeNewswire
- Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? [Yahoo! Finance]Yahoo! Finance
CPRX
Earnings
- 11/5/25 - Beat
CPRX
Sec Filings
- 1/12/26 - Form 8-K
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- CPRX's page on the SEC website